Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 438

1.

Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains.

Walker DG, Tang TM, Mendsaikhan A, Tooyama I, Serrano GE, Sue LI, Beach TG, Lue LF.

Int J Mol Sci. 2020 Jan 20;21(2). pii: E678. doi: 10.3390/ijms21020678.

2.

Impact of pre-therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV-specific T-cell therapy.

Walker DG, Shakya R, Morrison B, Neller MA, Matthews KK, Nicholls J, Smith C, Khanna R.

Clin Transl Immunology. 2019 Nov 5;8(11):e01088. doi: 10.1002/cti2.1088. eCollection 2019.

3.

Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology.

Mendsaikhan A, Tooyama I, Bellier JP, Serrano GE, Sue LI, Lue LF, Beach TG, Walker DG.

Acta Neuropathol Commun. 2019 Dec 21;7(1):215. doi: 10.1186/s40478-019-0862-8.

4.

Alzheimer's Disease Research Using Human Microglia.

Lue LF, Beach TG, Walker DG.

Cells. 2019 Aug 5;8(8). pii: E838. doi: 10.3390/cells8080838. Review.

5.

Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin.

Walker DG, Lue LF, Beach TG, Tooyama I.

Cells. 2019 Jul 23;8(7). pii: E766. doi: 10.3390/cells8070766.

6.

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.

Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM.

PLoS One. 2019 Jun 25;14(6):e0217566. doi: 10.1371/journal.pone.0217566. eCollection 2019.

7.

Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas.

Patil CG, Walker DG, Miller DM, Butte P, Morrison B, Kittle DS, Hansen SJ, Nufer KL, Byrnes-Blake KA, Yamada M, Lin LL, Pham K, Perry J, Parrish-Novak J, Ishak L, Prow T, Black K, Mamelak AN.

Neurosurgery. 2019 Oct 1;85(4):E641-E649. doi: 10.1093/neuros/nyz125.

PMID:
31069381
9.

Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.

Mendsaikhan A, Tooyama I, Walker DG.

Cells. 2019 Mar 11;8(3). pii: E230. doi: 10.3390/cells8030230. Review.

10.

Differences in Gene Expression Profiles and Phenotypes of Differentiated SH-SY5Y Neurons Stably Overexpressing Mitochondrial Ferritin.

Mendsaikhan A, Takeuchi S, Walker DG, Tooyama I.

Front Mol Neurosci. 2019 Jan 8;11:470. doi: 10.3389/fnmol.2018.00470. eCollection 2018.

11.

Pushing the envelope through the Global Financing Facility: potential impact of mobilising additional support to scale-up life-saving interventions for women, children and adolescents in 50 high-burden countries.

Chou VB, Bubb-Humfryes O, Sanders R, Walker N, Stover J, Cochrane T, Stegmuller A, Magalona S, Von Drehle C, Walker DG, Bonilla-Chacin ME, Boer KR.

BMJ Glob Health. 2018 Oct 2;3(5):e001126. doi: 10.1136/bmjgh-2018-001126. eCollection 2018. Erratum in: BMJ Glob Health. 2019 Jul 8;4(4):e001126corr1.

12.

Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.

Walker DG, Tang TM, Lue LF.

Exp Neurol. 2018 Nov;309:91-106. doi: 10.1016/j.expneurol.2018.07.016. Epub 2018 Aug 1.

13.

Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Ortuño-Lizarán I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N.

Mov Disord. 2018 Aug;33(8):1315-1324. doi: 10.1002/mds.27392. Epub 2018 May 8.

14.

Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition.

Jamison DT, Alwan A, Mock CN, Nugent R, Watkins D, Adeyi O, Anand S, Atun R, Bertozzi S, Bhutta Z, Binagwaho A, Black R, Blecher M, Bloom BR, Brouwer E, Bundy DAP, Chisholm D, Cieza A, Cullen M, Danforth K, de Silva N, Debas HT, Donkor P, Dua T, Fleming KA, Gallivan M, Garcia PJ, Gawande A, Gaziano T, Gelband H, Glass R, Glassman A, Gray G, Habte D, Holmes KK, Horton S, Hutton G, Jha P, Knaul FM, Kobusingye O, Krakauer EL, Kruk ME, Lachmann P, Laxminarayan R, Levin C, Looi LM, Madhav N, Mahmoud A, Mbanya JC, Measham A, Medina-Mora ME, Medlin C, Mills A, Mills JA, Montoya J, Norheim O, Olson Z, Omokhodion F, Oppenheim B, Ord T, Patel V, Patton GC, Peabody J, Prabhakaran D, Qi J, Reynolds T, Ruacan S, Sankaranarayanan R, Sepúlveda J, Skolnik R, Smith KR, Temmerman M, Tollman S, Verguet S, Walker DG, Walker N, Wu Y, Zhao K.

Lancet. 2018 Mar 17;391(10125):1108-1120. doi: 10.1016/S0140-6736(17)32906-9. Epub 2017 Nov 25. Review.

15.

Ballistic Phonon Penetration Depth in Amorphous Silicon Dioxide.

Yang L, Zhang Q, Cui Z, Gerboth M, Zhao Y, Xu TT, Walker DG, Li D.

Nano Lett. 2017 Dec 13;17(12):7218-7225. doi: 10.1021/acs.nanolett.7b02380. Epub 2017 Nov 7.

PMID:
29087722
16.

PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.

Du F, Yu Q, Yan S, Hu G, Lue LF, Walker DG, Wu L, Yan SF, Tieu K, Yan SS.

Brain. 2017 Dec 1;140(12):3233-3251. doi: 10.1093/brain/awx258.

17.

Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia.

Walker DG, Tang TM, Lue LF.

Front Aging Neurosci. 2017 Aug 9;9:244. doi: 10.3389/fnagi.2017.00244. eCollection 2017.

18.

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts.

Lue LF, Sabbagh MN, Chiu MJ, Jing N, Snyder NL, Schmitz C, Guerra A, Belden CM, Chen TF, Yang CC, Yang SY, Walker DG, Chen K, Reiman EM.

Front Aging Neurosci. 2017 Jul 24;9:226. doi: 10.3389/fnagi.2017.00226. eCollection 2017.

19.

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.

Lue LF, Guerra A, Walker DG.

Neurol Ther. 2017 Jul;6(Suppl 1):25-36. doi: 10.1007/s40120-017-0074-8. Epub 2017 Jul 21. Review.

20.

Tunable Mechanochemistry of Lithium Battery Electrodes.

Muralidharan N, Brock CN, Cohn AP, Schauben D, Carter RE, Oakes L, Walker DG, Pint CL.

ACS Nano. 2017 Jun 27;11(6):6243-6251. doi: 10.1021/acsnano.7b02404. Epub 2017 Jun 9.

PMID:
28575575
21.

Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings.

Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG.

Mov Disord. 2017 May;32(5):722-723. doi: 10.1002/mds.27044. No abstract available.

PMID:
28513078
22.

Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.

Walker DG, Lue LF, Tang TM, Adler CH, Caviness JN, Sabbagh MN, Serrano GE, Sue LI, Beach TG.

Neurobiol Aging. 2017 Jun;54:175-186. doi: 10.1016/j.neurobiolaging.2017.03.007. Epub 2017 Mar 16.

23.

Application of the WEPS and SWEEP models to non-agricultural disturbed lands.

Tatarko J, van Donk SJ, Ascough JC 2nd, Walker DG.

Heliyon. 2016 Dec 15;2(12):e00215. doi: 10.1016/j.heliyon.2016.e00215. eCollection 2016 Dec.

24.

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.

Wilkinson T, Sculpher MJ, Claxton K, Revill P, Briggs A, Cairns JA, Teerawattananon Y, Asfaw E, Lopert R, Culyer AJ, Walker DG.

Value Health. 2016 Dec;19(8):921-928. doi: 10.1016/j.jval.2016.04.015.

25.

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.

Teerawattananon Y, Tantivess S, Yamabhai I, Tritasavit N, Walker DG, Cohen JT, Neumann PJ.

Health Res Policy Syst. 2016 Dec 3;14(1):86.

26.

The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.

Dugger BN, Whiteside CM, Maarouf CL, Walker DG, Beach TG, Sue LI, Garcia A, Dunckley T, Meechoovet B, Reiman EM, Roher AE.

J Alzheimers Dis. 2016 Oct 4;54(3):1249. No abstract available.

PMID:
27716678
27.

Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.

Jiao SS, Shen LL, Zhu C, Bu XL, Liu YH, Liu CH, Yao XQ, Zhang LL, Zhou HD, Walker DG, Tan J, Götz J, Zhou XF, Wang YJ.

Transl Psychiatry. 2016 Oct 4;6(10):e907. doi: 10.1038/tp.2016.186.

28.

F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline.

Yan S, Du F, Wu L, Zhang Z, Zhong C, Yu Q, Wang Y, Lue LF, Walker DG, Douglas JT, Yan SS.

Diabetes. 2016 Nov;65(11):3482-3494. Epub 2016 Aug 23.

29.

When does a strategy intervention overcome a failure of inhibition? Evidence from two left frontal brain tumour cases.

Robinson GA, Walker DG, Biggs V, Shallice T.

Cortex. 2016 Jun;79:123-9. doi: 10.1016/j.cortex.2016.03.011. Epub 2016 Mar 23.

PMID:
27111106
30.

Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program.

Walker DG, Whetzel AM, Serrano G, Sue LI, Lue LF, Beach TG.

Cell Tissue Bank. 2016 Sep;17(3):361-75. doi: 10.1007/s10561-016-9555-8. Epub 2016 Apr 16.

31.

Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease.

Caviness JN, Lue LF, Hentz JG, Schmitz CT, Adler CH, Shill HA, Sabbagh MN, Beach TG, Walker DG.

Mov Disord. 2016 Jul;31(7):1012-9. doi: 10.1002/mds.26621. Epub 2016 Apr 8.

32.

The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.

Dugger BN, Whiteside CM, Maarouf CL, Walker DG, Beach TG, Sue LI, Garcia A, Dunckley T, Meechoovet B, Reiman EM, Roher AE.

J Alzheimers Dis. 2016;51(2):345-56. doi: 10.3233/JAD-150859. Erratum in: J Alzheimers Dis. 2016 Oct 4;54(3):1249.

33.

Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.

Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG.

Health Aff (Millwood). 2016 Feb;35(2):199-207. doi: 10.1377/hlthaff.2015.1086.

PMID:
26858370
34.

Converging mediators from immune and trophic pathways to identify Parkinson disease dementia.

Lue LF, Schmitz CT, Snyder NL, Chen K, Walker DG, Davis KJ, Belden C, Caviness JN, Driver-Dunckley E, Adler CH, Sabbagh MN, Shill HA.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(1):e193. doi: 10.1212/NXI.0000000000000193. eCollection 2016 Feb.

35.

Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases.

Walker DG, Lue LF, Serrano G, Adler CH, Caviness JN, Sue LI, Beach TG.

Front Neurosci. 2016 Jan 14;9:507. doi: 10.3389/fnins.2015.00507. eCollection 2015.

36.

Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings.

Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG.

Mov Disord. 2016 Feb;31(2):250-6. doi: 10.1002/mds.26476. Epub 2016 Jan 22.

37.

Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Intorcia A, Filon J, Scott S, Garcia A, Hoffman B, Belden CM, Davis KJ, Sabbagh MN; Arizona Parkinson's Disease Consortium.

J Parkinsons Dis. 2016;6(1):153-63. doi: 10.3233/JPD-150680.

38.

Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains.

Walker DG, Lue LF.

Alzheimers Res Ther. 2015 Aug 19;7(1):56. doi: 10.1186/s13195-015-0139-9. Review.

39.

Insulin Modulates In Vitro Secretion of Cytokines and Cytotoxins by Human Glial Cells.

Spielman LJ, Bahniwal M, Little JP, Walker DG, Klegeris A.

Curr Alzheimer Res. 2015;12(7):684-93.

PMID:
26159205
40.

Methodological variation in economic evaluations conducted in low- and middle-income countries: information for reference case development.

Santatiwongchai B, Chantarastapornchit V, Wilkinson T, Thiboonboon K, Rattanavipapong W, Walker DG, Chalkidou K, Teerawattananon Y.

PLoS One. 2015 May 7;10(5):e0123853. doi: 10.1371/journal.pone.0123853. eCollection 2015. Review.

41.

Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.

Andrus JK, Walker DG.

Vaccine. 2015 May 7;33 Suppl 1:A2-3. doi: 10.1016/j.vaccine.2015.01.001. No abstract available.

PMID:
25919161
42.

Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).

Brenzel L, Young D, Walker DG.

Vaccine. 2015 May 7;33 Suppl 1:A13-20. doi: 10.1016/j.vaccine.2014.12.066.

PMID:
25919153
43.

p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.

Yao XQ, Jiao SS, Saadipour K, Zeng F, Wang QH, Zhu C, Shen LL, Zeng GH, Liang CR, Wang J, Liu YH, Hou HY, Xu X, Su YP, Fan XT, Xiao HL, Lue LF, Zeng YQ, Giunta B, Zhong JH, Walker DG, Zhou HD, Tan J, Zhou XF, Wang YJ.

Mol Psychiatry. 2015 Nov;20(11):1301-10. doi: 10.1038/mp.2015.49. Epub 2015 Apr 28.

44.

Cognitive screening in brain tumors: short but sensitive enough?

Robinson GA, Biggs V, Walker DG.

Front Oncol. 2015 Mar 11;5:60. doi: 10.3389/fonc.2015.00060. eCollection 2015.

45.

Neuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment.

Dwan TM, Ownsworth T, Chambers S, Walker DG, Shum DH.

Front Oncol. 2015 Mar 11;5:56. doi: 10.3389/fonc.2015.00056. eCollection 2015.

46.

Verbal suppression and strategy use: a role for the right lateral prefrontal cortex?

Robinson GA, Cipolotti L, Walker DG, Biggs V, Bozzali M, Shallice T.

Brain. 2015 Apr;138(Pt 4):1084-96. doi: 10.1093/brain/awv003. Epub 2015 Feb 9.

PMID:
25665583
47.

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN.

Neuropathology. 2015 Aug;35(4):354-89. doi: 10.1111/neup.12189. Epub 2015 Jan 26.

48.

Dark energy from the string axiverse.

Kamionkowski M, Pradler J, Walker DG.

Phys Rev Lett. 2014 Dec 19;113(25):251302. Epub 2014 Dec 19.

PMID:
25554872
49.

Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.

Walker DG, Whetzel AM, Serrano G, Sue LI, Beach TG, Lue LF.

Neurobiol Aging. 2015 Feb;36(2):571-82. doi: 10.1016/j.neurobiolaging.2014.09.023. Epub 2014 Oct 2.

50.

Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme.

Schuessler A, Walker DG, Khanna R.

Front Oncol. 2014 Oct 7;4:275. doi: 10.3389/fonc.2014.00275. eCollection 2014. Review.

Supplemental Content

Loading ...
Support Center